Literature DB >> 15379653

Pharmacogenomics: the influence of genomic variation on drug response.

Fabienne J Thomas1, Howard L McLeod, James W Watters.   

Abstract

Unpredictable efficacy and toxicity are major hurdles in the administration of many medications. By identifying inherited DNA polymorphisms that influence drug disposition and effects, pharmacogenomics is an exciting tool for the individualization of drug therapies. Single nucleotide polymorphisms (SNP) in genes encoding drug metabolizing enzymes, drug transporters, and DNA repair genes have recently been shown to influence drug toxicity and efficacy. This review will discuss clinically relevant examples of genetic polymorphisms that influence the outcome of drug therapy, and possibilities for future applications of pharmacogenomics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379653     DOI: 10.2174/1568026043387638

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  8 in total

1.  Broad issues to consider for library involvement in bioinformatics.

Authors:  Renata C Geer
Journal:  J Med Libr Assoc       Date:  2006-07

2.  Minimum information required for a DMET experiment reporting.

Authors:  Judit Kumuthini; Mamana Mbiyavanga; Emile R Chimusa; Jyotishman Pathak; Panu Somervuo; Ron Hn Van Schaik; Vita Dolzan; Clint Mizzi; Kusha Kalideen; Raj S Ramesar; Milan Macek; George P Patrinos; Alessio Squassina
Journal:  Pharmacogenomics       Date:  2016-08-22       Impact factor: 2.533

Review 3.  Genetic diversity and new therapeutic concepts.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

4.  Relationship between initial treatment effect of recombinant human growth hormone and exon 3 polymorphism of growth hormone receptor in Chinese children with growth hormone deficiency.

Authors:  Zhangqian Zheng; Lingfeng Cao; Zhou Pei; Dijing Zhi; Zhuhui Zhao; Li Xi; Ruoqian Cheng; Feihong Luo
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Improvements to bead-based oligonucleotide ligation SNP genotyping assays.

Authors:  Shannon Bruse; Michael Moreau; Marco Azaro; Ray Zimmerman; Linda Brzustowicz
Journal:  Biotechniques       Date:  2008-11       Impact factor: 1.993

6.  Human SNPs resulting in premature stop codons and protein truncation.

Authors:  Sevtap Savas; Sukru Tuzmen; Hilmi Ozcelik
Journal:  Hum Genomics       Date:  2006-03       Impact factor: 4.639

7.  Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.

Authors:  Siew Lian Leong; Nathorn Chaiyakunapruk; Shaun Wen Huey Lee
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

8.  Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.

Authors:  Léon Nshimyumukiza; Julie Duplantie; Mathieu Gagnon; Xavier Douville; Diane Fournier; Carmen Lindsay; Marc Parent; Alain Milot; Yves Giguère; Christian Gagné; François Rousseau; Daniel Reinharz
Journal:  Thromb J       Date:  2013-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.